Product Code: 978-1-68038-867-1
Parenteral Nutrition Market Growth & Trends
The global parenteral nutrition market size is expected to reach USD 10.7 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth.
However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. With the increasing population, healthcare costs and food expenditures for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition levels, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period.
In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide. Furthermore, the presence of a large population base, aged above 60 years, suffering from low immunity levels, and prone to incidence of neurological diseases, cardiac problems, cancers, and spinal injuries, is a high-impact rendering driver for the parenteral lipid emulsions market over the forecast period. This population is expected to avail the latest surgical treatments, which is expected to increase their life span, thereby driving the need for intensive care & postoperative treatment, inclusive of PN products, such as lipid emulsions.
Parenteral Nutrition Market Report Highlights
- Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode-assisted medication.
- The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors
- Also, high infection rates, poor water quality & sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
- The single-dose amino acid solution nutrient type segment dominated the market in 2022 due to the introduction of newly available amino acid solutions with minimal side effects
- In 2022, the adult segment held the largest share due to increased adoption of parenteral nutrition products owing to the rising prevalence of various chronic diseases, such as Alzheimer's disease, sarcopenia, cancer, and diabetes among this age group
- The others indication segment dominated the market in 2022 due to the increased prevalence of Crohn's disease, cystic fibrosis, pancreatitis, other cancer-related treatment, and other health ailments
- In 2022, institutional sales channels dominated the market owing to the high number of private & public healthcare institutions and the increased patient population with chronic disease
- North America dominated the global market in 2022 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Research Process
- 1.2. Information Procurement
- 1.2.1. Purchased database
- 1.2.1.1. GVR's internal database
- 1.2.2. Market Formulation & Validation
- 1.3. Research Methodology
- 1.4. Research Scope and Assumptions
- 1.5. Research Methodology
- 1.5.1. Region Market: CAGR Calculation
- 1.5.2. Region Based Segment Share Calculation
- 1.6. List To Data Nutrient Type
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- 2.4. Parenteral Nutrition Market Snapshot
Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. User Perspective Analysis
- 3.2.1. Consumer Behavior Analysis
- 3.2.2. Market Influencer Analysis
- 3.3. Regulatory Framework
- 3.3.1. Reimbursement Framework
- 3.3.2. Standard & Compliance
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Industry Challenge
- 3.5. Parenteral Nutrition Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Bargaining power of the suppliers
- 3.5.1.2. Bargaining power of the buyers
- 3.5.1.3. Threats of substitution
- 3.5.1.4. Threats from new entrants
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Economic and Social landscape
- 3.5.2.3. Technological landscape
- 3.6. Impact of COVID 19 on Parenteral Nutrition Market
Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Parenteral Nutrition Market: Nutrient Type Movement Analysis, 2022 & 2030 (USD Million)
- 4.2.1. Carbohydrates
- 4.2.1.1. Carbohydrates Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Parenteral Lipid Emulsion
- 4.2.2.1. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.3. Single Dose Amino Acid Solution
- 4.2.3.1. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.4. Trace Elements
- 4.2.4.1. Trace Elements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.5. Vitamins & Minerals
- 4.2.5.1. Vitamins & Minerals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Parenteral Nutrition Market: Stage Type Movement Analysis, 2022 & 2030 (USD Million)
- 5.2.1. Adult
- 5.2.1.1. Adult Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Pediatrics
- 5.2.2.1. Pediatrics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Parenteral Nutrition Market: Indication Movement Analysis, 2022 & 2030 (USD Million)
- 6.2.1. Alzheimer's
- 6.2.1.1. Alzheimer's Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Nutrition Deficiency
- 6.2.2.1. Nutrition Deficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Cancer Care
- 6.2.3.1. Cancer Care Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Diabetes
- 6.2.4.1. Diabetes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.5. Chronic Kidney Disease
- 6.2.5.1. Chronic Kidney Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.6. Orphan Disease
- 6.2.6.1. Orphan Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.7. Dysphagia
- 6.2.7.1. Dysphagia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.8. Pain Management
- 6.2.8.1. Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.9. Malabsorption/GI Disorder/Diarrhea
- 6.2.9.1. Malabsorption/GI Disorder/Diarrhea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.10. Others
- 6.2.10.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Parenteral Nutrition Market: Sales Channel Movement Analysis, 2022 & 2030 (USD Million)
- 7.2.1. Online Sales
- 7.2.1.1. Online Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. Retail Sales
- 7.2.2.1. Retail Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Institutional Sales
- 7.2.3.1. Institutional Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis
- 8.1. Definition & Scope
- 8.2. Regional Market Share Analysis, 2022 & 2030
- 8.3. Regional Market Dashboard
- 8.4. Regional Market Snapshot
- 8.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
- 8.5.1. North America
- 8.5.1.1. North America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.1.2. U.S.
- 8.5.1.2.1. Key Country Dynamics
- 8.5.1.2.2. Competitive Scenario
- 8.5.1.2.3. Regulatory Framework
- 8.5.1.2.4. Reimbursement Scenario
- 8.5.1.2.5. U.S. Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.1.3. Canada
- 8.5.1.3.1. Key Country Dynamics
- 8.5.1.3.2. Competitive Scenario
- 8.5.1.3.3. Regulatory Framework
- 8.5.1.3.4. Reimbursement Scenario
- 8.5.1.3.5. Canada Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2. Europe
- 8.5.2.1. Europe Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.2. UK
- 8.5.2.2.1. Key Country Dynamics
- 8.5.2.2.2. Competitive Scenario
- 8.5.2.2.3. Regulatory Framework
- 8.5.2.2.4. Reimbursement Scenario
- 8.5.2.2.5. UK Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.3. Germany
- 8.5.2.3.1. Key Country Dynamics
- 8.5.2.3.2. Competitive Scenario
- 8.5.2.3.3. Regulatory Framework
- 8.5.2.3.4. Reimbursement Scenario
- 8.5.2.3.5. Germany Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.4. France
- 8.5.2.4.1. Key Country Dynamics
- 8.5.2.4.2. Competitive Scenario
- 8.5.2.4.3. Regulatory Framework
- 8.5.2.4.4. Reimbursement Scenario
- 8.5.2.4.5. France Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.5. Italy
- 8.5.2.5.1. Key Country Dynamics
- 8.5.2.5.2. Competitive Scenario
- 8.5.2.5.3. Regulatory Framework
- 8.5.2.5.4. Reimbursement Scenario
- 8.5.2.5.5. Italy Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.6. Spain
- 8.5.2.6.1. Key Country Dynamics
- 8.5.2.6.2. Competitive Scenario
- 8.5.2.6.3. Regulatory Framework
- 8.5.2.6.4. Reimbursement Scenario
- 8.5.2.6.5. Spain Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.7. Denmark
- 8.5.2.7.1. Key Country Dynamics
- 8.5.2.7.2. Competitive Scenario
- 8.5.2.7.3. Regulatory Framework
- 8.5.2.7.4. Reimbursement Scenario
- 8.5.2.7.5. Denmark Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.8. Sweden
- 8.5.2.8.1. Key Country Dynamics
- 8.5.2.8.2. Competitive Scenario
- 8.5.2.8.3. Regulatory Framework
- 8.5.2.8.4. Reimbursement Scenario
- 8.5.2.8.5. Sweden Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.2.9. Norway
- 8.5.2.9.1. Key Country Dynamics
- 8.5.2.9.2. Competitive Scenario
- 8.5.2.9.3. Regulatory Framework
- 8.5.2.9.4. Reimbursement Scenario
- 8.5.2.9.5. Norway Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3. Asia Pacific
- 8.5.3.1. Asia Pacific Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3.2. Japan
- 8.5.3.2.1. Key Country Dynamics
- 8.5.3.2.2. Competitive Scenario
- 8.5.3.2.3. Regulatory Framework
- 8.5.3.2.4. Reimbursement Scenario
- 8.5.3.2.5. Japan Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3.3. India
- 8.5.3.3.1. Key Country Dynamics
- 8.5.3.3.2. Competitive Scenario
- 8.5.3.3.3. Regulatory Framework
- 8.5.3.3.4. Reimbursement Scenario
- 8.5.3.3.5. India Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3.4. China
- 8.5.3.4.1. Key Country Dynamics
- 8.5.3.4.2. Competitive Scenario
- 8.5.3.4.3. Regulatory Framework
- 8.5.3.4.4. Reimbursement Scenario
- 8.5.3.4.5. China Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3.5. Australia
- 8.5.3.5.1. Key Country Dynamics
- 8.5.3.5.2. 8. 6. 3.5Competitive Scenario
- 8.5.3.5.3. Regulatory Framework
- 8.5.3.5.4. Reimbursement Scenario
- 8.5.3.5.5. Australia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3.6. Thailand
- 8.5.3.6.1. Key Country Dynamics
- 8.5.3.6.2. 8. Competitive Scenario
- 8.5.3.6.3. Regulatory Framework
- 8.5.3.6.4. Reimbursement Scenario
- 8.5.3.6.5. Thailand Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.3.7. South Korea
- 8.5.3.7.1. Key Country Dynamics
- 8.5.3.7.2. 8. 6. 3.7Competitive Scenario
- 8.5.3.7.3. Regulatory Framework
- 8.5.3.7.4. Reimbursement Scenario
- 8.5.3.7.5. South Korea Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.6 Latin America
- 8.5.6.1. Latin America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.6.2. Brazil
- 8.5.6.2.1. Key Country Dynamics
- 8.5.6.2.2. Competitive Scenario
- 8.5.6.2.3. Regulatory Framework
- 8.5.6.2.4. Reimbursement Scenario
- 8.5.6.2.5. Brazil Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.6.3. Mexico
- 8.5.6.3.1. Key Country Dynamics
- 8.5.6.3.2. Competitive Scenario
- 8.5.6.3.3. Regulatory Framework
- 8.5.6.3.4. Reimbursement Scenario
- 8.5.6.3.5. 6. 4.3.5 Mexico Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.6.4. Argentina
- 8.5.6.4.1. Key Country Dynamics
- 8.5.6.4.2. Competitive Scenario
- 8.5.6.4.3. Regulatory Framework
- 8.5.6.4.4. Reimbursement Scenario
- 8.5.6.4.5. Argentina Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.7. MEA
- 8.5.7.1. MEA Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.7.2. South Africa
- 8.5.7.2.1. Key Country Dynamics
- 8.5.7.2.2. Competitive Scenario
- 8.5.7.2.3. Regulatory Framework
- 8.5.7.2.4. Reimbursement Scenario
- 8.5.7.2.5. South Africa Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.7.3. Saudi Arabia
- 8.5.7.3.1. Key Country Dynamics
- 8.5.7.3.2. Competitive Scenario
- 8.5.7.3.3. Regulatory Framework
- 8.5.7.3.4. Reimbursement Scenario
- 8.5.7.3.5. Saudi Arabia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.7.4. UAE
- 8.5.7.4.1. Key Country Dynamics
- 8.5.7.4.2. Competitive Scenario
- 8.5.7.4.3. Regulatory Framework
- 8.5.7.4.4. Reimbursement Scenario
- 8.5.7.4.5. UAE Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.5.7.5. Kuwait
- 8.5.7.5.1. Key Country Dynamics
- 8.5.7.5.2. Competitive Scenario
- 8.5.7.5.3. Regulatory Framework
- 8.5.7.5.4. Reimbursement Scenario
- 8.5.7.5.5. Kuwait Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Key Company Market Position Analysis
- 9.3. Key Company Market Share Analysis
- 9.4. Recent Development and Impact Analysis, by key Market Participants
- 9.5. Company Profiles
- 9.5.1. Braun Melsungen AG
- 9.5.1.1. Company Overview
- 9.5.1.2. Financial Performance
- 9.5.1.3. Product Benchmarking
- 9.5.1.4. Strategic initiatives
- 9.5.2. Fresenius kabi AG
- 9.5.2.1. Company Overview
- 9.5.2.2. Financial Performance
- 9.5.2.3. Product Benchmarking
- 9.5.2.4. Strategic initiatives
- 9.5.3. Allergan
- 9.5.3.1. Company Overview
- 9.5.3.2. Financial Performance
- 9.5.3.3. Product Benchmarking
- 9.5.3.4. Strategic initiatives
- 9.5.4. Grifols S.A.
- 9.5.4.1. Company Overview
- 9.5.4.2. Financial Performance
- 9.5.4.3. Product Benchmarking
- 9.5.4.4. Strategic initiatives
- 9.5.5. Pfizer Inc.
- 9.5.5.1. Company Overview
- 9.5.5.2. Financial Performance
- 9.5.5.3. Product Benchmarking
- 9.5.5.4. Strategic initiatives
- 9.5.6. Otsuka Pharmaceutical Factory, Inc
- 9.5.6.1. Company Overview
- 9.5.6.2. Financial Performance
- 9.5.6.3. Product Benchmarking
- 9.5.6.4. Strategic initiatives
- 9.5.7. Baxter
- 9.5.7.1. Company Overview
- 9.5.7.2. Financial Performance
- 9.5.7.3. Product Benchmarking
- 9.5.7.4. Strategic initiatives
- 9.5.8. Aculife
- 9.5.8.1. Company Overview
- 9.5.8.2. Financial Performance
- 9.5.8.3. Product Benchmarking
- 9.5.8.4. Strategic initiatives
- 9.5.9. Sichuan Kelun Pharmaceutical Co., Ltd
- 9.5.9.1. Company Overview
- 9.5.9.2. Financial Performance
- 9.5.9.3. Product Benchmarking
- 9.5.9.4. Strategic initiatives
- 9.5.10. Vifor Pharma
- 9.5.10.1. Company Overview
- 9.5.10.2. Financial Performance
- 9.5.10.3. Product Benchmarking
- 9.5.10.4. Strategic initiatives